Anthony E. Ting

3.6k total citations · 1 hit paper
60 papers, 2.8k citations indexed

About

Anthony E. Ting is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Anthony E. Ting has authored 60 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 19 papers in Genetics and 17 papers in Surgery. Recurrent topics in Anthony E. Ting's work include Mesenchymal stem cell research (19 papers), Tissue Engineering and Regenerative Medicine (10 papers) and Pluripotent Stem Cells Research (5 papers). Anthony E. Ting is often cited by papers focused on Mesenchymal stem cell research (19 papers), Tissue Engineering and Regenerative Medicine (10 papers) and Pluripotent Stem Cells Research (5 papers). Anthony E. Ting collaborates with scholars based in United States, Singapore and United Kingdom. Anthony E. Ting's co-authors include Richard H. Scheller, Shu-Chan Hsu, Nicole Calakos, Jonathan Pevsner, Janice E.A. Braun, M K Bennett, Robert Deans, Richard E. Pagano, Yee‐Joo Tan and Robert W. Mays and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Anthony E. Ting

58 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Specificity and regulation of a synaptic vesicle docking complex

1994 517 citations Jonathan Pevsner, Shu-Chan Hsu et al. Neuron profile →

Peers

Countries citing papers authored by Anthony E. Ting

Since Specialization

Citations

This map shows the geographic impact of Anthony E. Ting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony E. Ting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony E. Ting more than expected).

Fields of papers citing papers by Anthony E. Ting

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony E. Ting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony E. Ting. The network helps show where Anthony E. Ting may publish in the future.

Co-authorship network of co-authors of Anthony E. Ting

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony E. Ting. A scholar is included among the top collaborators of Anthony E. Ting based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony E. Ting. Anthony E. Ting is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Artificial intelligence, machine learning, and digitalization systems in the cell and gene therapy sector: a guidance document from the ISCT industry committees 2025 ·Cytotherapy ·Vincenzo Di Cerbo, Hannah Song, (unknown), Sean J. Hart, (unknown), Shanya Jiang, Abeer Madbouly, (unknown), (unknown), Anand Srinivasan, (unknown), Anthony E. Ting, Shannon Eaker, (unknown)	1
2	Considerations for the development of iPSC-derived cell therapies: a review of key challenges by the JSRM-ISCT iPSC Committee 2024 ·Cytotherapy ·(unknown), Uma Lakshmipathy, (unknown), Kapil Bharti, Dominic Wall, Yoji Sato, George F. Muschler, Anthony E. Ting, N. Smith, (unknown), Shin Kawamata, Jennifer C. Moore, (unknown), Stephen Sullivan, (unknown), Arwa Z. Al‐Riyami	29
3	Delivery of multipotent adult progenitor cells via a functionalized plasma polymerized surface accelerates healing of murine diabetic wounds 2023 ·Frontiers in Bioengineering and Biotechnology ·Stuart J. Mills, Giles T. S. Kirby, (unknown), Louise E. Smith, Patrick Statham, Bart Vaes, Anthony E. Ting, Robert D. Short, Allison J. Cowin	4
4	Proceedings of the ISCT scientific signature series symposium, “Advances in cell and gene therapies for lung diseases and critical illnesses” 2022 ·Cytotherapy ·Anthony E. Ting, (unknown), Josée Champagne, Tushar Desai, Claúdia C. dos Santos, Irene H. Heijink, Silviu Itescu, Katarina Le Blanc, Michael A. Matthay, Daniel F. McAuley, (unknown), Shirley H. J. Mei, Biju Parekkadan, Patrícia R. M. Rocco, John T. Sheridan, Bernard Thébaud, Daniel J. Weiss	3
5	Safety and efficacy of multipotent adult progenitor cells in acute respiratory distress syndrome (MUST-ARDS): a multicentre, randomised, double-blind, placebo-controlled phase 1/2 trial 2021 ·Intensive Care Medicine ·Geoff Bellingan, (unknown), Jonathan Bannard‐Smith, David Brealey, Nuala J. Meyer, David Thickett, Duncan Young, Andrew Bentley, Bryan J. McVerry, Richard G. Wunderink, Kevin C. Doerschug, Charlotte Summers, Mauricio Rojas, Anthony E. Ting, Elinor Jenkins	26
6	The Delivery of Multipotent Adult Progenitor Cells to Extended Criteria Human Donor Livers Using Normothermic Machine Perfusion 2020 ·Frontiers in Immunology ·Richard W. Laing, (unknown), Lorraine Wallace, Valerie D. Roobrouck, Ricky H. Bhogal, Andrea Schlegel, Yuri L. Boteon, Gary Reynolds, Anthony E. Ting, Darius F. Mirza, Philip N. Newsome, Hynek Mergental, Simon C. Afford	45
7	Development of a Functional Biomarker for Use in Cell-Based Therapy Studies in Seropositive Rheumatoid Arthritis 2016 ·Stem Cells Translational Medicine ·(unknown), David Soler, Anthony E. Ting, Nicholas Lehman, (unknown), Thomas S. McCormick, Donald D. Anthony, Hillard M. Lazarus, Arnold I. Caplan, (unknown), Nora G. Singer	2
8	Development of a surrogate angiogenic potency assay for clinical-grade stem cell production 2012 ·Cytotherapy ·Nicholas Lehman, Rochelle Cutrone, Amy Raber, R.R. Perry, Wouter Van’t Hof, Robert Deans, Anthony E. Ting, Juliana Woda	49
9	Allogeneic stem cell transplantation for ischemic myocardial dysfunction 2012 ·Current Opinion in Organ Transplantation ·Anthony E. Ting, Warren Sherman	5
10	Abstract 9926: Molecular Imaging of the Pro-angiogenic Paracrine Effects of Stem Cell Therapy 2011 ·Circulation ·(unknown), Yue Qi, (unknown), Todd Belcik, Aris Xie, Brian P. Davidson, Yan Zhao, Juliana Woda, Anthony E. Ting, Jonathan R. Lindner	2
11	Multipotent Adult Progenitor Cells Prevent Macrophage-Mediated Axonal Dieback and Promote Regrowth after Spinal Cord Injury 2011 ·Journal of Neuroscience ·Sarah A. Busch, Jason A. Hamilton, Kevin P. Horn, Fernando X. Cuascut, Rochelle Cutrone, Nicholas Lehman, Robert Deans, Anthony E. Ting, Robert W. Mays, Jerry Silver	119
12	Global Characterization and Genomic Stability of Human MultiStem, A Multipotent Adult Progenitor Cell. 2009 ·PubMed ·Sherry Boozer, Nicholas Lehman, Uma Lakshmipathy, Brad Love, Amy Raber, (unknown), Robert Deans, Mahendra S. Rao, Anthony E. Ting	47
13	A Novel Cell Cycle Inhibitor Stalls Replication Forks and Activates S Phase Checkpoint 2007 ·Cell Cycle ·Vaidehi Krishnan, Léon Dirick, Hong Hwa Lim, (unknown), (unknown), (unknown), Kai Lee Yap, Anthony E. Ting, Étienne Schwob, Uttam Surana	8
14	Therapeutic pathways of adult stem cell repair 2007 ·Critical Reviews in Oncology/Hematology ·Anthony E. Ting, Robert W. Mays, Mark R. Frey, Wouter Van’t Hof, Satish Medicetty, Robert Deans	34
15	Development of Homogeneous High-Affinity Agonist Binding Assays for 5-HT ₂ Receptor Subtypes 2005 ·Assay and Drug Development Technologies ·Jianping Song, Douglas Hanniford, (unknown), E. Scott Graham, (unknown), Anthony E. Ting, Bruce A. Sherf, John Harrington, Kurt R. Brunden, Alain Stricker‐Krongrad	20
16	Evaluation of functional and binding assays in cells expressing either recombinant or endogenous hERG channel 2005 ·Journal of Pharmacological and Toxicological Methods ·Steven M. Murphy, (unknown), (unknown), Linas Padegimas, (unknown), (unknown), (unknown), (unknown), Anthony E. Ting, Bruce A. Sherf, Kurt R. Brunden, Alain Stricker‐Krongrad	25
17	A small inhibitor of the interaction between Bax and Bcl-X L can synergize with methylprednisolone to induce apoptosis in Bcl-X L -overexpressing breast-cancer cells 2003 ·Journal of Cancer Research and Clinical Oncology ·Yee‐Joo Tan, Eileen Teng, Anthony E. Ting	9
18	Biophysical Characterization of the Oligomeric State of Bax and Its Complex Formation with Bcl-XL 1999 ·Biochemical and Biophysical Research Communications ·Yee‐Joo Tan, Walter Beerheide, Anthony E. Ting	26
19	Insights into the Molecular Mechanisms of Synaptic Vesicle Docking and Fusion 1995 ·Cold Spring Harbor Symposia on Quantitative Biology ·Anthony E. Ting, Richard H. Scheller	5
20	Specificity and regulation of a synaptic vesicle docking complex breakdown → 1994 ·Neuron ·Jonathan Pevsner, Shu-Chan Hsu, Janice E.A. Braun, Nicole Calakos, Anthony E. Ting, M K Bennett, Richard H. Scheller	517

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact